IGF1R and neoplasm: As a selective IGF1R inhibitor, OSI-906 inhibits the growth and survival of tumor cells by blocking the tyrosine kinase activity of IGF1R and inhibiting the activation of downstream signaling pathways (Liu et al., 2022).